Compare Novo Nordisk A/S (NVO) vs Trade Desk Inc (TTD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Trade Desk Inc — how do they compare? Novo Nordisk A/S trades at $45.93 (market cap $207.85B), while Trade Desk Inc trades at $13.54 (market cap $6.37B). The key difference: Novo Nordisk A/S is far larger — about 32.6× Trade Desk Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Trade Desk Inc pays none. Which is the better fit depends on your goals.
| NVO | TTD | |
|---|---|---|
Market Cap | $207.85B | $6.37B |
Sector | Health | Technology |
52-Week High | $63.98 | $55.36 |
52-Week Low | $35.29 | $13.39 |
Enterprise Value | $222.55B | $5.32B |
Dividend Yield | 3.81% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →
